Caricamento...
Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β(2)-Agonists
BACKGROUND: Bronchodilators are used for managing the symptoms of chronic obstructive pulmonary disease (COPD) and minimizing the risk of hospitalization and readmission. Hospital readmission is predictive of morbidity and mortality. OBJECTIVE: The study objective was to compare all-cause readmissio...
Salvato in:
| Pubblicato in: | Drugs Real World Outcomes |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5332308/ https://ncbi.nlm.nih.gov/pubmed/27864792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-016-0097-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|